NL301037I1 - - Google Patents

Info

Publication number
NL301037I1
NL301037I1 NL301037C NL301037C NL301037I1 NL 301037 I1 NL301037 I1 NL 301037I1 NL 301037 C NL301037 C NL 301037C NL 301037 C NL301037 C NL 301037C NL 301037 I1 NL301037 I1 NL 301037I1
Authority
NL
Netherlands
Application number
NL301037C
Other versions
NL301037I2 (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37085728&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL301037(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of NL301037I1 publication Critical patent/NL301037I1/nl
Publication of NL301037I2 publication Critical patent/NL301037I2/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/12—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
NL301037C 2005-06-08 2020-03-30 Solriamfetol of een farmaceutisch aanvaardbaar zout daarvan, bij voorkeur het hydrochloridezout daarvan NL301037I2 (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68863805P 2005-06-08 2005-06-08
PCT/US2006/022407 WO2006133393A1 (en) 2005-06-08 2006-06-07 Treatment of sleep-wake disorders

Publications (2)

Publication Number Publication Date
NL301037I1 true NL301037I1 (nl) 2020-04-01
NL301037I2 NL301037I2 (nl) 2020-05-12

Family

ID=37085728

Family Applications (1)

Application Number Title Priority Date Filing Date
NL301037C NL301037I2 (nl) 2005-06-08 2020-03-30 Solriamfetol of een farmaceutisch aanvaardbaar zout daarvan, bij voorkeur het hydrochloridezout daarvan

Country Status (16)

Country Link
US (6) US8440715B2 (nl)
EP (1) EP1890684B1 (nl)
JP (1) JP5024635B2 (nl)
KR (1) KR101335941B1 (nl)
CN (1) CN101217949B (nl)
AU (1) AU2006254899B2 (nl)
BR (1) BRPI0613697A2 (nl)
CA (1) CA2611713C (nl)
DK (1) DK1890684T3 (nl)
ES (1) ES2435403T3 (nl)
FR (1) FR20C1014I2 (nl)
NL (1) NL301037I2 (nl)
PL (1) PL1890684T3 (nl)
RU (1) RU2417077C2 (nl)
TW (2) TW201328689A (nl)
WO (1) WO2006133393A1 (nl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0613697A2 (pt) 2005-06-08 2011-01-25 Sk Holdings Co Ltd tratamento de distúrbios de sono-vigìlia
WO2007001841A1 (en) * 2005-06-22 2007-01-04 Sk Holdings Co., Ltd. Treatment of sexual dysfunction
EP2445490B1 (en) * 2009-06-22 2023-02-08 SK Biopharmaceuticals Co., Ltd. Methods for treating or preventing fatigue
US8232315B2 (en) * 2009-06-26 2012-07-31 Sk Biopharmaceuticals Co., Ltd. Methods for treating drug addiction and improving addiction-related behavior
CA2779457C (en) 2009-11-06 2017-10-17 Sk Biopharmaceuticals Co., Ltd. Methods for treating attention-deficit/hyperactivity disorder
ES2743153T3 (es) * 2009-11-06 2020-02-18 Sk Biopharmaceuticals Co Ltd Métodos para tratar el síndrome de fibromialgia
US8623913B2 (en) * 2010-06-30 2014-01-07 Sk Biopharmaceuticals Co., Ltd. Methods for treating restless legs syndrome
US9610274B2 (en) 2010-06-30 2017-04-04 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
ES2927675T3 (es) * 2013-03-13 2022-11-10 Jazz Pharmaceuticals Ireland Ltd Tratamiento de la cataplexia
KR102309836B1 (ko) 2013-07-18 2021-10-12 에스케이바이오팜 주식회사 비만의 치료
TWI698415B (zh) 2014-02-28 2020-07-11 南韓商愛思開生物製藥股份有限公司 胺基羰基胺基甲酸酯化合物
US10888542B2 (en) 2014-02-28 2021-01-12 Sk Biopharmaceuticals Co., Ltd. Aminocarbonylcarbamate compounds
WO2016061488A1 (en) * 2014-10-17 2016-04-21 Concert Pharmaceuticals, Inc. Amine reuptake inhibitors
JP6466792B2 (ja) * 2015-07-03 2019-02-06 エスケー バイオファーマスティカルズ カンパニー リミテッド 注意欠陥／多動性障害（ａｄｈｄ）の治療方法
TWI637765B (zh) * 2016-05-10 2018-10-11 台灣共振波研發股份有限公司 Soothing device for attention deficit hyperactivity disorder
US10195151B2 (en) 2016-09-06 2019-02-05 Jazz Pharmaceuticals International Iii Limited Formulations of (R)-2-amino-3-phenylpropyl carbamate
JP7219213B2 (ja) * 2016-09-06 2023-02-07 ジャズ ファーマスティカルズ アイルランド リミテッド （ｒ）－２－アミノ－３－フェニルプロピルカルバメートの溶媒和物フォーム
US10710958B2 (en) * 2016-10-06 2020-07-14 Jazz Pharmaceuticals Ireland Limited Carbamoyl phenylalaninol compounds and uses thereof
CA3065522A1 (en) 2017-06-02 2018-12-06 Jazz Pharmaceuticals Ireland Limited Methods and compositions for treating excessive sleepiness
JP7366002B2 (ja) * 2017-07-31 2023-10-20 ジャズ ファーマシューティカルズ アイルランド リミテッド カルバモイルフェニルアラニノール類縁体およびその使用
US10940133B1 (en) 2020-03-19 2021-03-09 Jazz Pharmaceuticals Ireland Limited Methods of providing solriamfetol therapy to subjects with impaired renal function
US11033214B1 (en) * 2020-05-19 2021-06-15 United Arab Emirates University Wearable eye tracking system
KR102390194B1 (ko) 2020-08-03 2022-04-25 셀라이온바이오메드 주식회사 페닐알킬 카바메이트 화합물을 포함하는 Kca3.1채널 매개질환 치료용 조성물

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2939660A1 (de) * 1979-09-29 1981-04-16 Basf Ag, 6700 Ludwigshafen Neue carbamate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen
CZ285829B6 (cs) 1993-06-10 1999-11-17 Eli Lilly And Company Použití derivátu tetrahydrobenz [c,d]indolu pro výrobu farmaceutického prostředku vhodného pro ošetřování sexuální dysfunkce
KR100197892B1 (ko) 1994-09-09 1999-06-15 남창우 신규한 페닐알킬아미노 카바메이트 화합물과 그의 제조방법
US5756817C1 (en) * 1995-02-11 2001-04-17 Sk Corp O-carbamoyl-phenylananinol compounds their pharmaceutically useful salts and process for preparing the same
KR0173862B1 (ko) * 1995-02-11 1999-04-01 조규향 O-카바모일-(d)-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법
KR0173863B1 (ko) * 1995-04-10 1999-04-01 조규향 페닐에 치환체가 있는 o-카바모일-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법
WO1998015526A1 (en) * 1996-10-10 1998-04-16 Sk Corporation O-carbamoyl-phenylalaninol compounds, their pharmaceutically useful salts and process for preparing the same
AU4674797A (en) 1996-10-22 1998-05-15 Ortho Pharmaceutical Corporation Phenylalaninol derivatives for the treatment of central nervous system disorders
PL364639A1 (en) * 2001-02-27 2004-12-13 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating anxiety disorders
BR0207644A (pt) * 2001-02-27 2004-03-09 Ortho Mcneil Pharm Inc Compostos de carbamato para uso na prevenção ou no tratamento de distúrbio bipolar
IL157592A0 (en) * 2001-02-27 2004-03-28 Ortho Mcneil Pharm Inc Carbamate compounds for use in preventing or treating movement disorders
US20050080268A1 (en) 2003-10-08 2005-04-14 Yong-Moon Choi Process of preparing O-carbamoyl compounds in the presence of active amine group
US20050203130A1 (en) * 2003-12-02 2005-09-15 Erik Buntinx Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
RU2007119648A (ru) 2004-10-28 2008-12-10 СК Холдингз Ко. Способ лечения депрессии
BRPI0613697A2 (pt) 2005-06-08 2011-01-25 Sk Holdings Co Ltd tratamento de distúrbios de sono-vigìlia
WO2007001841A1 (en) 2005-06-22 2007-01-04 Sk Holdings Co., Ltd. Treatment of sexual dysfunction
AU2005335241B9 (en) 2005-07-26 2012-12-20 Sk Biopharmaceuticals Co., Ltd. Methods for treating substance-related disorders
MX2009003926A (es) 2006-10-13 2009-06-26 Janssen Pharmaceutica Nv Composiciones de fenilalquilamino-carbamato.
EP2445490B1 (en) 2009-06-22 2023-02-08 SK Biopharmaceuticals Co., Ltd. Methods for treating or preventing fatigue
US8232315B2 (en) 2009-06-26 2012-07-31 Sk Biopharmaceuticals Co., Ltd. Methods for treating drug addiction and improving addiction-related behavior
ES2743153T3 (es) 2009-11-06 2020-02-18 Sk Biopharmaceuticals Co Ltd Métodos para tratar el síndrome de fibromialgia
CA2779457C (en) 2009-11-06 2017-10-17 Sk Biopharmaceuticals Co., Ltd. Methods for treating attention-deficit/hyperactivity disorder
US8623913B2 (en) 2010-06-30 2014-01-07 Sk Biopharmaceuticals Co., Ltd. Methods for treating restless legs syndrome
US9610274B2 (en) 2010-06-30 2017-04-04 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
KR102005483B1 (ko) 2012-10-19 2019-07-31 삼성디스플레이 주식회사 박막 트랜지스터 기판 및 그의 수리 방법
ES2927675T3 (es) * 2013-03-13 2022-11-10 Jazz Pharmaceuticals Ireland Ltd Tratamiento de la cataplexia

Also Published As

Publication number Publication date
JP2008545795A (ja) 2008-12-18
US20190367448A1 (en) 2019-12-05
CN101217949B (zh) 2012-10-17
EP1890684A1 (en) 2008-02-27
US20130137764A1 (en) 2013-05-30
US20090312416A1 (en) 2009-12-17
DK1890684T3 (da) 2013-10-14
US9604917B2 (en) 2017-03-28
TW200716084A (en) 2007-05-01
AU2006254899B2 (en) 2011-11-24
JP5024635B2 (ja) 2012-09-12
CN101217949A (zh) 2008-07-09
AU2006254899A1 (en) 2006-12-14
BRPI0613697A2 (pt) 2011-01-25
FR20C1014I1 (nl) 2020-06-12
US8877806B2 (en) 2014-11-04
TW201328689A (zh) 2013-07-16
US8440715B2 (en) 2013-05-14
NL301037I2 (nl) 2020-05-12
US20170158622A1 (en) 2017-06-08
US20140350098A1 (en) 2014-11-27
PL1890684T3 (pl) 2014-05-30
US11753368B2 (en) 2023-09-12
RU2417077C2 (ru) 2011-04-27
RU2008100019A (ru) 2009-07-20
TWI419681B (zh) 2013-12-21
ES2435403T3 (es) 2013-12-19
CA2611713A1 (en) 2006-12-14
US20210078943A1 (en) 2021-03-18
WO2006133393A1 (en) 2006-12-14
KR20080035565A (ko) 2008-04-23
CA2611713C (en) 2013-10-01
FR20C1014I2 (fr) 2021-04-23
KR101335941B1 (ko) 2013-12-04
EP1890684B1 (en) 2013-08-14
US10351517B2 (en) 2019-07-16

Similar Documents

Publication Publication Date Title
FR20C1014I1 (nl)
IN2008DE04405A (nl)
JP2006275797A5 (nl)
AP2140A (nl)
JP2006231012A5 (nl)
JP2005337505A5 (nl)
JP2007042664A5 (nl)
JP2007030038A5 (nl)
JP2006303255A5 (nl)
JP2007023549A5 (nl)
JP2006166406A5 (nl)
JP2007059447A5 (nl)
JP2006229898A5 (nl)
CN105122969C (nl)
CN300726015S (zh) 鞋底
CN300726005S (zh) 鞋帮
CN300726696S (zh) 调料瓶套装(c)
CN300726695S (zh) 调料瓶套装(a)
CN300726592S (zh) 碗用具（双壁式4）
CN300726591S (zh) 冷冰食品制作器
CN300726508S (zh) 头部遮挡板
CN300726222S (zh) 包装纸(金色高金火腿肠)
CN300726016S (zh) 鞋帮
CN300725999S (zh) 鞋底
CN300725997S (zh) 鞋帮